Conference abstract · 28 May 2018
Conference abstractPublished 2018
Adjuvants and vaccines a millenium evolution
IRT BIOSASTER, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Since the first use of vaccination in the early 8th century to current time, vaccines have emerged as a biggest live saving intervention after clean water. Vaccines have followed an evolution following the evolution of technologies and scientific knowledge, and can be different in nature and purpose opening the door to their use not only to fight infectious diseases but also creating hope for the control and treatment of chronic disorders and cancer. Progresses in the understanding of the key role of the innate and adaptive immunity in the induction of protection to infection, have had an impact on their design and the search for constant improvement of the efficacy and safety profile observed. Since the introduction of aluminium as the first adjuvant, several new adjuvants have been licensed in the context of various human vaccines. Their development has led to a new appreciation of the various steps to be undertaken to reach licensure, from research to licensure, including preclinical toxicology evaluation. The increased understanding of the innate and adaptive immune responses, host pathogen interactions, and the emergence of new and improved technologies over time, has shaped the way this was tackled, streamlined the necessary interaction required across the various bodies and expertise, providing a holistic approach to their development and licensure.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 9 Nov 2017
Targeted vaccination and intrinsic adjuvant function: next generation checkpoint control of tumor specific B and T cells
Conference abstract · 2 Nov 2017
Adjuvanted allogeneic breast cancer vaccine: Maximizing cancer treatment by modulating the host immunity
Conference abstract · 13 Sep 2017
Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumorcell vaccination in mice
Conference abstract · 17 Jul 2017
Cancer stem cell vaccine significantly reduced local tumor relapse and prolonged animal survival in the adjuvant setting
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Review article · 3 Jul 2025
Efficacy of interventions for newly diagnosed multiple myeloma: An umbrella review
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Nathalie Garcon”

